🇺🇸 FDA
Patent

US 11299486

Benzazole compounds and methods for making and using the compounds

granted A61KA61K31/454A61K31/4545

Quick answer

US patent 11299486 (Benzazole compounds and methods for making and using the compounds) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/454, A61K31/4545, A61K31/496, A61K31/5377